Wellbeing champion | Evolving the menopause discussion: Difficult HRT decisions

By Tracey Ward, Head of Business Development & Marketing at Generali UK Employee Benefits

Workplace activity to inform and educate about menopause should arguably also include a focus on difficult Hormone Replacement Therapy (HRT) decisions, according to the experts we spoke to as part of a recent webinar.

Because, in spite of Davina McCall’s best efforts to highlight evidence that long-held links between HRT and breast cancer might not be as watertight as previously believed (more on this later), the decision about whether or not to take HRT, remains tough for many. And not only for those with a history of breast cancer, but also for women with other potential complications, such as being on long-term medication.

We recently brought together experts to provide us with their wisdom on this topic; from what is HRT, whether it is safe and when should you start taking it, to considerations when you have potential complications. This article includes some of the highlights of this webinar.*